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The cDNA encoding the @ subunit of the human high-affinity IgE receptor was cloned by a combination of various polymcrasc chain reactions 
(PCR). A major portion of thefi cDNA was amplilicd using primers homologous within the sequences ofrat and mouse, The 3’ unknown sequence 
was preferentially amplified using the RNA template-specific PCR and the inrprovcd IWO-S&~ PCR. The 5’ unknown sequence was specifically 
amplified by our newly dcvclopcd PCR walking. Random hcptanuclcotidcs tagged with a unique squence at the 5’ end were used as the walking 
primer. Finally, the entire coding region was amplified and scqucnccd. The twoextracellular loopsofthe humanSsubunit were the least homologous 
to those of rat and mouse, 
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I. INTRODUCTION 
The high affinity receptor for IgE (Fc&RI) is found 
exclusively on mast cells and basophils. When this re- 
ceptor is aggregated by binding multivalent allergens 
via receptor-bound IgE, these cells are stimulated and 
release allergic and inflammatory mediators. FcsRI is 
composed of four polypeptide chains: a single c1 chain, 
a single /3 chain, and two disulfide-linked y chains [I ,2]. 
cDNAs coding for the rat 01 [3-S], /I [6] and y [7] sub- 
units were cloned and sequenced from basophilic leuke- 
mia (RBL) cells. Mouse cDNAs for all three subunits 
were cloned from a mast cell line PTl8 [8]. cDNAs 
corresponding to the human u and y subunits were 
cloned from a mast cell line KU812 [4,9] and a leukocyte 
genomic library [IO], respectively. The human p sub- 
unit, however. remains to be cloned. Despite findings 
that the extracellular domain of’ the human a subunit 
was sufficient for high affinity IgE binding [I 1,121 and 
that the rat and mouse,0 subunits were indispensable for 
expression of the corresponding FCERIS on transfected 
ceils [8,13] and for the receptor-mediated signal 
transduction [14], the role of the human/3 subunit is still 
obscure: the human (x subunit that co-transfected with 
the y but not with the B subunit was expressed on the 
cell sur;>ce [8,13] and transduced weak but substantial 
signals [14]. 
plifications and the sequence was compared with those 
of the rodent. Since KU812 cells failed to release hista- 
mine after Fc&RI aggregation and mutations on the 
receptor cannot be denied entirely [IS], basophils ob- 
tained by culture of mononuclear cells from human 
umbilical cord blood [ 161 were used for isolation of the 
/I cDNA. 
2. MATERIALS AND METHODS 
Mononuclear cells from human umbilical cord blood wcrc cultured 
in media facilitating the growth and differentiation of basophils as 
described [l6]. Briefly, mononuclear cells were obtained from hepar- 
inizcd human umbilical cord blood using FicoWaque (I .077 mglml: 
Pharmacia LKB), suspended aI 2 x IOn cells/ml in RPM1 1640 medium 
supplemcntcd with iO% fetal calfserum, 0,05 mM 2-mercaptoethanol, 
2 mM I.-glu!zminc. antibiotics (IO0 Ll ofpenicillin, 0.05 mgofslrep:o- 
mycin. and 0.025 mg of gcntamycin per ml) and 200 LVml of recombi- 
nant human IL-3 (Genzymc. Boston, MA) and cultured for 24 weeks. 
The nonudherent cells, 15-308 ofwhich were Fc&RI positive (&lo not 
shown), were used for isolation of RNA. 
2.2. isobrion ?f RNA 
Total RNA was isolated from approximately IO’ cultured cells by 
the acid guanidium-pl~cnol-chloroform method [I 71. mRNA was iso- 
lated from approximately IO7 cilltured cells using a QuickPrep mRNA 
Purification Kit as recommended by the supplier (Phartnacia LKB). 
2.3. Ofigotluck?orilk synrllcssis 
In this study, the cDNA encoding the human ,8 sub- 
unit was cloned by a combination of various PCR am- 
Correspo~r&~~e uticlrcss: S. Harada, Shionogi Institute for Mcdicdl 
Science, 2-S-1, Mishhna, Se&u-&i, Osaka 566, Jap;in. Fax: (81) (6) 
3822598. 
Oligonuclcotides were synthesized using a DNA synthesizer (CY- 
CLONE, MilliGen. Bedford, MA). purified through Oligo-Pak col- 
umn (MilliGen) and used as Ihe prirncr for PCR or sequencing. The 
positions of the representative PCR primers are indicated in Fig. 3. 
Primers dcsignatcd as El3 are eicosanuclcotides that are homologous 
in the rat and mouse /I cDNA czequences: EBl primer is identical o 
the sequence in the NH,-terminal cytoplasmic (IC) tail of the rat 
(nucleotides 75-94, ref. [6] and mouse (nucleotides 43-62. ref. [8] B 
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Fig. I, Amplification and sequencing of the 5’ unknown region of the 
human F~ERL p cDNA by a novel PCR walking. Some o!‘walking 
primers, random heptanuclcotidcs (N7) tag& with a unique sequence 
(Ca) at the 5’ ml, hybridized to rurious sites in the 5’ unknown 
sequence (open bar) upstream from the known scquuncc (hatched bar) 
of the (W-strand human fi cDNA and primed to synthesize sccond- 
strand cDNAs. The resulting double-stranded cDNAs of various 
Icngths were subjected to the subsequent PCR atnplificarion. During 
the first cycle of the tirst-step PCR, only the known sequence-specific 
primer EBHB hybridized to the second-strand p cDNAs and primed 
to synthesize :he double-stranded humanD EDNA fragments contain- 
ing a unique sequence at 5’ end, The resulting cDNA fragments ofp 
subunit were specifically amplified during the 2nd-30th cycles of the 
first-step PCR using a pair ofprimers(EBH8 and the unique scquencc- 
specific Cal), By use of a pair of inner primers (EBH6 and Ca?), lhc 
5’ unknown sequences ofthc humanp cDNA were l’urtlier specifically 
amplified by the 2nd.step PCR. The ampliBcd DNA fragments, even 
though different in length, wcrc sequenced directly by using the known 
sequence-specific primer EBH6. 
cDNAs. EBB primer is complementary tothe scqucnce in the COOH- 
terminal transmcmbrane (TM) 4 scgmcnt of the rat (606625) and 
mouse (550-569). EBB primer is complcmcntury to the sequence inthe 
COGH-trrmiuui IC tail (726-745 ior rat; W-684 ior mouse). Prinicrs 
designated as EBH (odd numbers) and EBH (even numbers) are re- 
spectively identical and complementary to the human p cDNA sc- 
quenced in this study (Fig. 4): EBHS (nuclcotides 532-551). EBH6 
(YO-109), EBH7 (505-524) EBHS (134-153). EBHIS (-55 to -32). 
EBH17 (-28 to -9) EBHl8 (767-786) EBH22 (829-844). NP.45 
primer (S’GACTACiTTCTAGATCCiCG3’) and NPA3 primer (5’A- 
GCGGCCGCCCTTTTT3’) are identical to the sequences in the 5’ 
end and middle of /Vorl Primer-Adapter (Cat No. 8248SA, A I; BRL, 
Gaitherburg, MD), respectively. CaN, primer is random heptanucleo- 
tides (N,) tagged with a unique sequence (Ca, S’GTACA- 
TATTGTCGTTAGAACGCGTAATACCiACTCACTATAGGGA- 
GA3’) at 5’ und. Cu I and Cu2 primers xc the 5’. and 3’.halves of the 
unique sequcncc (Ca). respectively. 
2.4. PCR 
2.4. I. Amplification of a major portion of the p cDNA 
Using the isolated total RNA as the template and oligo (dT),$ 
(Borhringer, Mannhcim, Germany) as the primer, first strand cDNA 
synthesis was catalyzed by M-MLV reverse transcriptase (BRL) ac- 
cording to the recommcndcd protocols. By use of the resulting first- 
strund cDNA as the template and a pair of EBI and EB6 primers, the 
cDNA encoding the sequence between the NH,-terminal IC tail and 
the COOH-terminal TM4 segment wds amplified by PCR. First- 
strand EDNA equivalent o approximate!y 2.5 pg of total RNA and 
100 pmol of each primer were used in a 100 ,ul reaction mixture 
containing 20 pmol of each deoxynucleotidc and 2.5 U of AmpliTaq 
DNA polymeruse from a GcncAmp DNA Amplification Reagent Kit 
(Cctus, Norwalk, CT). After 30 cycles of denaturation (94°C for I 
min), annealing (6OOC for I min) and extension (72’C for 90 s) in a 
DNA Thermal Cyclcr (Cetus), the amplified cDNA fragment was 
purified by electrophoresis in a 2.5% agarose gel. 
2.4.2, Amplification of the 3’.end sequences of the p cDNA 
Using the isolated niRNA as the template, the first-strand cDNA 
was synthesized using SWRSCRI~ Plasmid System (BRL): 
Sura~Sc~wr RT as the revcrsc transcriptase and (Vorl Primer-Adapter 
as the prhncr, By use of the resulting first-strand cDNA containing 
a unique sequence of No11 Primer-Adapter at 5’ end as the templute, 
the cDNA coding for the COOH-terminal TM4 IO the poly(A) seg 
ment was amplified using the improved two-step PCR [IS]. Briefly, 
first-strand cDNA corresponding to about 0.14~6 of mRNA. was first 
amplified us described in 2.4.1, with the following modifications: (I) 
us little as IO prnol each of EBH7 and NPAS primers were used: (2) 
the mixture was incubated for 25 cycles (94°C for 1 min, 50°C for I 
min, and 72°C for 3 mm). A 1.~1 aliquot of the reaction mixture was 
again amplified for 30 cycles as in the first process except hat 100 
pmol each of EBHS and NPA3 primers were used. The amplilicd 
DNA fragment wrs purified by 2.5% agarose gel clcctrophoresis. 
2.4.3. Amphlicdlion of the S-end sequences of the p cDNA 
Our newly developed PCR walking in the 5’ unknown sequence is 
outlined in Fig. I. The second-strand reaction was catalyzed by Ampli- 
Taq DNA polymcrasc (Cetus) using the ftrst-strand cDNA synthe- 
sized as described in 2.4. I, as the template and CaN, oligonucleotides 
as the walking primers. The mixture wus incubated in a DNA thermal 
Cyclcr (Cclus) for one cycle (94OC for IO min, 37OC for 30 min, 37 
+ 72°C for 30 min. and 72°C for 30 min). By use of the resulting 
double- stranded cDNAs as the template, the cDNAs encoding the 
NH:- terminal IC tail and the preceding 5’ upstream non-coding re- 
gion were amplifted using the improved two-step PCR [18]. After the 
first-step PCR using 10 pmol each of EBH8 and Cal primers for 30 
cycles (94°C for I min. 55°C for I min, and 72OC for 2 min). a lyl 
aliquot of the reaction mixture was subjected to the second-step PCR 
using 100 pmol etch of EBH6 and Ca2 primers, using the same cycle 
incubation as in the Arst-step PCR. and purified by electrophorcsis. 
2.4.4. Amplitication of the entire coding sequcncc of the ,& cDNA 
Using the lirst-strand cDNA synthesized as described in 2.4.2. as 
the template. the fDNA containing the full coding region xts ampli- 
ficd by the improved two-siep PCR [IQ Briefly, first-strand cDNA 
corresponding toapproximately 0.19yg ofmRNA was first amplified 
using IO pmol each of EBHIS and EBH22 primers for 30 cycles of 
incubation (94OC for I min, 45OC for 80 s, and 72OC for 3 min). A 3;ul 
162 
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(Cl aliquot of the reaction mixture was re-amplified using 100 pmol each 
of EBH17 and EBHl8 primers for 25 cycles of incubation (94’C for 
I mitt, 55°C for I min. and 72% for 2 mm), and purified by electro- 
phoresis. 
PCR-amplified cDNA fragments were directly sequenced with Se- 
quenase Version 2,O (Code No. 70772; United States Biochemical, 
Clcvcland) using [a-“)P]dCTP or with the dsDNA Cycle Sequencing 
System (BRL) according to the manufacturer’s instructions. The 
cDNA fragment subcloned into an EcoRV-digested pBluescript 
SK(-) vector (Stratagcne, La Jolla. CA) was also sequenced using SK 
and KS primers following the supplier’s protocol. 
3. RESULTS AND DISCUSSION 
3.1. AnzpliJicarion urd sequencirtg ala major portion of 
the B cDNA 
Based on the cDNA sequences coding for the /I sub- 
unit of rat [6] and mouse [8], eight 20.mer oligonucleo- 
tides (designated as EBl-8) homologous with the rat 
and mouse sequences were synthesized. A total of 10 
PCR amplifications were performed using a pair of EB 
(odd numbers) and EB (even numbers) oligonucleotides 
as primers. All four amplifications using the EB8 primer 
were unsuccessful, and the pair of El31 and EB6 primers 
gave the largest and reasonable sized product 550 bp 
(arrowed in Fig. 2A). Only the EB8 primer had a 3’.end 
nucleotide mismatched with the human p cDNA se- 
quenced in this study (nucleotide 670 in Fig. 4), which 
may have resulted in poor amplification. 
Fig. 2. PCR umplifieation of a major portion (A), the 5’ end (B), the 
3’ end (C) and the entire coding sequence (D) of the human Fe&RI p 
cDNA, Amplified products (lane P) wcrc separated by 2.5% agarose 
gel electrophorcsis and stained with cthidium bromide. The arrowed 
bands were excised from the gel and purified. Lane M is a DNA size 
marker. @Xl74/Hir?cII digest. 
The PCR-amplified cDNA fragment (EBl-EBB) en- 
coding a major portion of the human p subunit between 
the NH2-terminal IC tail and the COOH-terminal TM4 
segment (Fig. 3) was sequenced irectly or after sub- 
cloning into pBluescript (data not shown). 
specifically the 3’-end sequence of the human /I subunit. 
In the RS-PCR, RNA-derived sequences are pref’eren- 
tially amplified by using a first-strand cDNA containing 
a unique sequence at the 5’ end as the template and a 
pair of known sequence-specific and unique sequence- 
specific primers. In the improved two-step PCR, high 
specificity and sensitivity by the conventional two-step 
PCR [20] using first outer, then inner primers nested 
within the first primers, are further improved by reduc- 
ing the amount of both the first primers and the second 
template (i.e. the first reaction mixture). 
3,2, Extension to he Y-end sequences 
The RNA template-specific PCR (RS-PCR) [ 191 and 
the improved two-step PCR [I81 were used to amplify 
NotI Primer-Adapter, containing a unique 29.base 
sequence to the 5’ side of oligo (dT)iS, hybridized to the 
poly(A) segment of mRNA and primed to synthesize a
first-strand cDNA, which was used as the template in 
PCR-amplification of the 3’.end sequence. NPAS and 
NPA3 oligonucleotides corresponding to the 5’ end and 
middle of Nor1 Primer-Adapter, espectively, were used 
0 200 420 600 800 (bp) 
h I I I I I I I I I 
TM1 TM2 TM3 TM4 
5’ 3’ 
CBSL EB$6 t-l3ll8 EBlZii3ti6 NPEPAB 
EBliii”l7 EB&i &22 
Fig. 3. The positions of the representative PCR primers, The scale indicates nueleotide positions (in bp) beginning from the first base of the initiation 
codon for the human FURI @ cDNA. Beneath the scale the coding region of the human B subunit scqucnced in this study is indicated by boxes: 
solid, TM segment: hatched, IC tail; cross-hatched, IC loop and open, EC loop. Bars rcprescnl non-coding scqucnces. The arrows illustrate the 
direction and extent of DNA sequences of the reprcscnlah PCR primers. 
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CCR’TPCniOGWYiC-ATA- 
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W-- ccAocAocATm 
RNATYLVRQSLQANTASSIA 
0ClUAl'ZA~CTi'QGCCTATAltCAC 
GQTQfTILItNLKKSLAYIH 
>:----A-- 
IHSCQKFFETKCPMASFBTR 
ATTGTi&QATJAlUC~~- 
1VVMMLFLT:LQLQSAVSLT 
AWTQPITCWTWTWPPTA~ 
ICQAQEELXQNKVPEDRVYE 
WTl’AAWATATA-AClTACMWM--Cm 
BLNIYSATYSELEDPQEMSP 
CXCATIUA'l'l'IATAAQhA-TC-- -TccaA 
PIDL- 
Fig. 4. Nucleotide sequence and predicted amino acid sequence of the 
human Fc&RI,B subunit. The numbers on the Icl’l refer to the nuclco- 
tide number beginning 81 the start codon at position + I; nuclcotidcs 
preceding it are represented by negative numbers. 
as unique sequence.specific primers. EBH5 and EBH7 
oligonucleotides corresponding to the 3’ end sequences 
of the PCR-product (EBl-EBB) were used as known 
sequence-specific primers (Fig. 3). 
The 5’ unknown region of the human /3 subunit was 
successfully amplified and sequenced by our newly de- 
veloped PCR walking (Fig. 1). Random heptanucleo- 
tides (N,) tagged with a unique 46.base sequence to 
their 5’ side (CaN? oligonucleotides) were used as the 
walking primer. Some of them hybridized to the 5’ up- 
stream from the known sequence (EBl-EBB) of the 
first-strand @ cDNA and primed to synthesize second- 
strand cDNAs containing a unique sequence at the 5’ 
end. The second-strand cDNAs derived from the 
human,8 subunit were specifically amplified by a combi- 
nation of the RS-PCR and the improved two-step PCR 
as described in 3.2. Cal and Ca2 primers equivalent to 
the 5’ and 3’ sides of the unique 46-base sequence (Ca), 
respectively, were used as unique sequence-specific 
primers. EBH6 and EBH8 oligonucleotides correspond- 
ing to the S’-end sequences of the PCR-products (EBl- 
EBB) were used as known sequence-specific primers 
(Fig. 3). A total of 12 PCR-amplifications produced 
major DNA fragments of around 200 bp. In some am- 
plifications, larger- and some smaller-sized DNA frap 
ments were produced. A representative amplification is 
shown in Fig, 2B. The major fragments of around 200 
bp (arrowed in Fig. 2B) from the six amplifications were 
sequenced and found all identical to the sequence cod- 
ing for the region upstream from the NH$erminal IC 
tail (data not shown). Other larger fragments were re- 
vealed as being unrelated. These 200 bp fragments are 
thought o cover the most 5’ end of the human B cDNA 
amplified. 
3.4. AtnpbJ’ccrriot? and sequencing of he entire codhg 
region of rite p cDNA 
The PCR-amplified cDNA fragment (EBHS-NPA3) As shown in Fig. 3, the three PCR products (EBl- 
encoding the TM4 to the poly(A) segment (approxi- EB6, EBHS-NPA3 and Ca2-EBH6) could be con- 
mately 550 bp as arrowed in Fig. 2C) was sequenced nected in sequence, and the human p cDNA sequence 
directly (data not shown). containing the entire coding region was presumed. 
3.3. Exrension to the 5’ end sequerlces 
nlumn 
Rat 
MOlW 
numm 
Rat 
Mow 
~ESNRRANLAZIP--QEPSSVP~~TSPQEVSSQRLLKS~SPP~~~KKEQEFLILT~CLCFGTWCSVLDISBa: 
MDTEMCSRADLALPNPQESPS~DI~~PP~PE--KPASPPPQQTG9QSILKKELEIF~~~~LICLCFGTWCSTLQTSDF 
MDT~SRAD~PNPQESSSAPDIELL~P~---------- PPKQTWRTFLKKELEFLCWI'Q~LVQLICLCFWIVCSVLY'VSDF 
**** ** l *** ** * t l ** l * ** ** **** **** l * l **t**** **, * l 
ml 
EQD~FSSFKAGYPFWG~FFSTS(3MLSTIS~~~GSLSI~~ITILIIl~KKISLAY~HIHSCQIFS 
DDE%lLLLYRPaWPEWGAVLFVLSWLSTMS ~~~S~VSSI~~IAI:LI~SNNSA~CK-DI~~FVTSFI 
D~~YPF6QGS~FLSIISER~~~QS~IVSSI~T(3IAMLI~~A~CK-F~~DGC~~~ 
***A**+ * ** *** *+* l ********** **** * ** ** ** l * ** ** 9 
!lw ma3 
TEIWMMLFLTIMLBSAVSLTICQSGEiEL ~EDR~EELNIYSATYS~~P~~PPIDL 
TEL~BLTILAFCSWIIYRIOQEFERSMfPDDRLYE~SPIY~~~~S 
~~LTfLAFCETI~I~Q~~SK~PDD~YE~SP~YS~~KQE~SSP~S 
l * l * **t*** l ** l ** *** ** **** ** ** l ** *** 
mc 
Fig. 5. Alignment of the predicted amino acid sequences of the human, rat, and mouse FcsRI p subunits. The three proteins are aligned to obtain 
maximum identity using the ALIGN program developed hy Dr, Yasuo lna (National Institute ofGenetics, Japan). Dashes indicate &dpS introduced 
to improve the alignment. Residues identical in all three spucics are indicated with asterisks, TM segmcnls 14 underlined arc presumed with 
rei’erence to those or the rat [6] and mouse [8] p subunits. 
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Based on the putative sequence thus obtained, a total 
of 27 eicosanucleotiries (designated as EBH) wcri: syn- 
!hc,ajzc:! BCFOSS the r.caucnce in both directions, and 
used as primers to amplify and mhn the whoir cod- 
ing sequence. 
Using nested primers corresponding to 5’ upstream 
and 3’ downstream non-coding sequences, a cDNA con- 
taining the full coding region was amplified using the 
improved two-step PCR as shown by an arrow in Fig. 
2D. The PCR-amplified cDNA was sequenced irectly 
using various EBH primers (data not shown), and the 
conclusive nucleotide sequence and predicted amino 
acid sequence of the human FcERI b subunit was ob- 
tained as described in Fig. 4. 
3.5. C/~arucrerisrics of he predicied mine acid sequence 
The hydrophobicity profile analyzed for the predicted 
amino acid sequence of the human p subunit is similar 
to those for the rat [6] and mouse [8] p subunits and has 
four characteristic hydrophobic regions corresponding 
to the TM segments I-4 (data not shown). The amino 
acid sequences of the p subunits in three species were 
compared (Fig. 5) All four TM segments and an IC 
loop between TM2 and TM3 are well conserved, 
whereas the two extracellular (EC) loops are the least 
conserved regions. The percentages of identical residues 
of the EC loops are 18% between TM 1 and TM2 and 
33% between TM3 and TM4. Since the rat and mouse 
p subunits are highly homologous (82% in the entire 
sequence and more than 70% in any corresponding re- 
gions; refs. [63 and [8]), the two EC loops of the human 
p subunit are especially less homologous to those of the 
rodents. Furthermore, the EC loop between TM3 and 
TM4 of the human p subunit is characteristic in the 
number of acidic and basic residues resulting in being 
positively charged (+2) for human, but negative (-4 and 
-3) for rat and mouse, respectively. According to the 
positive- inside rule for integral membrane proteins 
[21,22], segments with positively charged residues flank- 
ing the apolar regions are found on the intracellular, 
non-translocated side. We are now investigating 
whether the human p subunit is expressed in the same 
topology as the rat [6] and mouse [8] /i subunits, or 
following the positive- inside rule, i.e. the loop between 
TM3 and TM4 remains on the inside of the membrane. 
A~kno,vi~~~~cr,tr)i/~: WC arc grmful to Dr. Yorio Hinutna, director of 
the Shionogi lnslitutc for Medical Science. for his encouragement. WC 
would like to thank MISS Yumi Kosada for technical assistance. 
REFERENCES 
[I] Metzeccr, H., Kinct, J.-P., Perez-Momfort, R., Rivnay. B. and 
Wank, S.A. (1983) Prog. Immun, 5.493-501. 
[2] Mctzgcr. H. (1991) Clin. Exp. Allergy 21, 269-279. 
[3] Kinct. J.-P.. Metzger. H., Hakimi, J. and Kochan. J. (1987) Bio- 
chemistry 26, 4605-4610. 
[41 
[51 
[61 
t71 
181 
R 
1161 
[Ill 
Shim& A,, Teplcr. I., Benfey, P.N., Berenstcin, E.H., Sira- 
ganian. R.P, and Lcdcr. P. (1988) Proc, Nati. Aead. Sci. USA 85. 
1907-191 I. 
Liu. F.-T., Albrundt. K. and Robertson, M.W. (1988) Proo. Natl. 
Acad. Sci. USA 85. 5639-5643. 
Kinet, J.-P., Blank, U., Ru, C.. White, K.. Metzger. H. and 
Kochan, J. (1988) Proc. Natl. Acud. Sci. USA 85.64836487. 
Biank, U.. Ra, C., Miller, L., While, K.. Metzger. H. and Kinet, 
J.-P. (1989) Nature 337, 187-189. 
Ra. C.. Jouvin. M.mH.E. and Kinct, J.-P. (1989) 1. Biol, Chcm. 
264. 15323-I 5327. 
Kochun. J.. Pcltiue, L.F., Hakimi. J.. Kishi, K. and Kinct. J.P. 
(1988) Nucleic Acids Rcs. 16. 3584. 
Kilstcr. H., Thompson. H. and Kinet, J.-P. (1990) J. Biol. Chem. 
265, 6W86452. 
Hakimi, 1.. Seals, C.. Kondas, J-A.. Pctrinc, L.. Danho, W. and 
Kochun. J. (1990) J. Biol. Chcm. 265. 22079-22081. 
[12] Blank. U.. RP, C. and Kinet. J.-P. (1991) J. Biol. Chcm. 266. 
2639-2646. 
[I31 Miller. L,, Blank, U.. Metzger, H. and Kinet, J.-P. (1989) Science 
244, 334-337. 
[14] Albcn. G.. Miller. L.. Jelscma, CL.. Varin-Blank. N. and Mcta- 
ger. H. (1991) J. Biol. Chem. 266. X613-22620. 
1151 Fischkoff, S.A., Kishi, K., Benjamin, W.R.. Rossi. R.M., 
Hoessly, MC., Hoxie. J.A., Seals, C., Anderson, L., Ishika. T. 
and Hakimi, J, (19.87) Leukemia Research Il. 1105-l 113. 
[I61 Saito, H.. Hutakc, K.. Dvorak, A.M., Leifurman, K.M., Donnen- 
berg. A.D., Ardi, N., Ishizaka. K. and Ishizaka, T. (1988) Proc. 
Natl. Acdd. Sci. USA 85. 22882292. 
[ 171 Chomczynski. P. and Sacchi. N. (1987) Anal. B&hem. 162, l56- 
159. 
[IS] Aono, Y.. Imai, J., Tominaga, K.. Orita, 8, Sato. A. and Iga- 
rashi, H, (1992) Virus Genes 6,93-105. 
[I91 Shuldincr, A.R., Nirula, A. and Roth, J. (1990) Gcnc 91, l39- 
142. 
[?O] Mullis, K.B. and Fsloona. F.A. (1987) Methods Enzymol. 155. 
335-350. 
[?I] von Heijne, G. and Gavel, Y. (1988) Eur. J. Uioohcm. 174,67l- 
678. 
[22] Andcrsson, H.. Bukker, E. and von Heijnc, G. (1992) J. Biol. 
Chem. 267. 1491-1495. 
165 
